vs
Side-by-side financial comparison of IT TECH PACKAGING, INC. (ITP) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
IT TECH PACKAGING, INC. is the larger business by last-quarter revenue ($25.6M vs $20.4M, roughly 1.3× Sight Sciences, Inc.). IT TECH PACKAGING, INC. runs the higher net margin — -5.7% vs -20.4%, a 14.8% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs 2.1%). IT TECH PACKAGING, INC. produced more free cash flow last quarter ($1.5M vs $-2.0M). Over the past eight quarters, IT TECH PACKAGING, INC.'s revenue compounded faster (10.5% CAGR vs 2.9%).
IT TECH PACKAGING, INC. is a paper manufacturing enterprise primarily operating in China. It produces and distributes a diverse portfolio of paper products including corrugated packaging paper, boxboard, and printing-use cultural paper, serving sectors such as consumer goods packaging, logistics, and commercial printing across its core market.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
ITP vs SGHT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.6M | $20.4M |
| Net Profit | $-1.4M | $-4.2M |
| Gross Margin | 7.9% | 87.3% |
| Operating Margin | -3.9% | -18.0% |
| Net Margin | -5.7% | -20.4% |
| Revenue YoY | 2.1% | 6.9% |
| Net Profit YoY | 26.6% | 64.9% |
| EPS (diluted) | $-0.11 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $20.4M | ||
| Q3 25 | $25.6M | $19.9M | ||
| Q2 25 | $24.8M | $19.6M | ||
| Q1 25 | $10.9M | $17.5M | ||
| Q4 24 | $17.6M | $19.1M | ||
| Q3 24 | $25.1M | $20.2M | ||
| Q2 24 | $26.2M | $21.4M | ||
| Q1 24 | $6.9M | $19.3M |
| Q4 25 | — | $-4.2M | ||
| Q3 25 | $-1.4M | $-8.2M | ||
| Q2 25 | $-2.0M | $-11.9M | ||
| Q1 25 | $-3.5M | $-14.2M | ||
| Q4 24 | $-4.0M | $-11.8M | ||
| Q3 24 | $-2.0M | $-11.1M | ||
| Q2 24 | $-77.7K | $-12.3M | ||
| Q1 24 | $-3.7M | $-16.3M |
| Q4 25 | — | 87.3% | ||
| Q3 25 | 7.9% | 86.4% | ||
| Q2 25 | 5.1% | 84.8% | ||
| Q1 25 | 0.8% | 86.2% | ||
| Q4 24 | 6.3% | 86.8% | ||
| Q3 24 | 7.6% | 83.9% | ||
| Q2 24 | 12.4% | 85.8% | ||
| Q1 24 | 5.8% | 85.5% |
| Q4 25 | — | -18.0% | ||
| Q3 25 | -3.9% | -39.7% | ||
| Q2 25 | -7.1% | -59.6% | ||
| Q1 25 | -31.0% | -79.2% | ||
| Q4 24 | -21.5% | -62.5% | ||
| Q3 24 | -5.8% | -55.7% | ||
| Q2 24 | 2.1% | -59.2% | ||
| Q1 24 | -51.0% | -76.4% |
| Q4 25 | — | -20.4% | ||
| Q3 25 | -5.7% | -41.0% | ||
| Q2 25 | -7.9% | -61.0% | ||
| Q1 25 | -32.2% | -80.8% | ||
| Q4 24 | -22.9% | -62.1% | ||
| Q3 24 | -7.9% | -54.9% | ||
| Q2 24 | -0.3% | -57.7% | ||
| Q1 24 | -54.6% | -84.4% |
| Q4 25 | — | $-0.07 | ||
| Q3 25 | $-0.11 | $-0.16 | ||
| Q2 25 | $-0.16 | $-0.23 | ||
| Q1 25 | $-0.35 | $-0.28 | ||
| Q4 24 | $-0.40 | $-0.23 | ||
| Q3 24 | $-0.20 | $-0.22 | ||
| Q2 24 | $-0.01 | $-0.25 | ||
| Q1 24 | $-0.37 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $92.0M |
| Total DebtLower is stronger | $4.7M | $42.4M |
| Stockholders' EquityBook value | $152.0M | $63.9M |
| Total Assets | $175.7M | $115.3M |
| Debt / EquityLower = less leverage | 0.03× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $92.0M | ||
| Q3 25 | — | $92.4M | ||
| Q2 25 | — | $101.5M | ||
| Q1 25 | — | $108.8M | ||
| Q4 24 | — | $120.4M | ||
| Q3 24 | — | $118.6M | ||
| Q2 24 | — | $118.2M | ||
| Q1 24 | — | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | $4.7M | $42.4M | ||
| Q2 25 | $4.7M | $42.4M | ||
| Q1 25 | $4.7M | $42.4M | ||
| Q4 24 | $4.7M | $40.0M | ||
| Q3 24 | $8.9M | $37.1M | ||
| Q2 24 | $11.3M | $35.0M | ||
| Q1 24 | $11.4M | $35.0M |
| Q4 25 | — | $63.9M | ||
| Q3 25 | $152.0M | $64.3M | ||
| Q2 25 | $152.3M | $70.0M | ||
| Q1 25 | $152.8M | $77.6M | ||
| Q4 24 | $156.1M | $87.5M | ||
| Q3 24 | $164.3M | $95.0M | ||
| Q2 24 | $163.5M | $101.6M | ||
| Q1 24 | $164.3M | $109.2M |
| Q4 25 | — | $115.3M | ||
| Q3 25 | $175.7M | $116.3M | ||
| Q2 25 | $175.2M | $122.0M | ||
| Q1 25 | $175.2M | $129.7M | ||
| Q4 24 | $177.5M | $142.8M | ||
| Q3 24 | $190.0M | $143.6M | ||
| Q2 24 | $191.4M | $149.7M | ||
| Q1 24 | $177.5M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | 0.03× | 0.66× | ||
| Q2 25 | 0.03× | 0.61× | ||
| Q1 25 | 0.03× | 0.55× | ||
| Q4 24 | 0.03× | 0.46× | ||
| Q3 24 | 0.05× | 0.39× | ||
| Q2 24 | 0.07× | 0.34× | ||
| Q1 24 | 0.07× | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.5M | $-1.8M |
| Free Cash FlowOCF − Capex | $1.5M | $-2.0M |
| FCF MarginFCF / Revenue | 5.9% | -9.7% |
| Capex IntensityCapex / Revenue | 0.0% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $1.5M | $-8.7M | ||
| Q2 25 | $1.4M | $-7.5M | ||
| Q1 25 | $-2.5M | $-11.6M | ||
| Q4 24 | $3.5M | $-3.5M | ||
| Q3 24 | $1.5M | $362.0K | ||
| Q2 24 | $721.9K | $-9.5M | ||
| Q1 24 | $624.4K | $-9.8M |
| Q4 25 | — | $-2.0M | ||
| Q3 25 | $1.5M | $-8.9M | ||
| Q2 25 | $1.3M | $-7.8M | ||
| Q1 25 | $-2.5M | — | ||
| Q4 24 | $3.5M | $-3.6M | ||
| Q3 24 | $1.2M | $311.0K | ||
| Q2 24 | $668.3K | $-9.5M | ||
| Q1 24 | $615.4K | $-9.9M |
| Q4 25 | — | -9.7% | ||
| Q3 25 | 5.9% | -44.7% | ||
| Q2 25 | 5.4% | -39.6% | ||
| Q1 25 | -22.8% | — | ||
| Q4 24 | 19.6% | -18.9% | ||
| Q3 24 | 4.9% | 1.5% | ||
| Q2 24 | 2.5% | -44.7% | ||
| Q1 24 | 9.0% | -51.4% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 0.1% | 1.1% | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 0.1% | 0.7% | ||
| Q3 24 | 1.0% | 0.3% | ||
| Q2 24 | 0.2% | 0.4% | ||
| Q1 24 | 0.1% | 0.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ITP
Segment breakdown not available.
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
